Tibet AIM Pharm. Inc.

¥15.04As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002826Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.96%)
Div yield 1.00%
ROE 13.44%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.47
PE TTM 25.09
TSR TTM (24.48%)
Mkt cap ¥2.859B
ROIC 37.47%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥18
20.09%
(45.30%)
Hold 10|1|12|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.26
0.28
0.29
0.32
20.16%
31.19%
32.50%
31.15%
Revenue¥M
137.7
136.7
143.0
148.1
3.52%
3.20%
9.89%
10.24%
Peers (US$428.5M)
Cap (US$)
PE
436.6M
—
428.3M
49.33x
Capital
TTM
5Y
10Y
Leveragex
1.611
0.072
0.062
EBIT/Intx
0.507
0.422
0.473
Own earn%
(8.17)
205.14
201.88
Sh yield%
17.14
36.27
39.39
Owners
Insiders/Inst%
8.04
45.84
Short interest%
3.62
SBC / revenue%
3.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
13–23
$1 testx
1.3
Incr. ROIC%
7